Ascletis Pharma Inc. (OTCMKTS:ASCLF) Short Interest Up 20.8% in March

Ascletis Pharma Inc. (OTCMKTS:ASCLF) was the target of a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 810,726 shares, an increase of 20.8% from the February 26th total of 670,868 shares. Based on an average daily volume of 350 shares, the short-interest ratio is currently 2,316.4 days.

Ascletis Pharma Price Performance

OTCMKTS ASCLF opened at $1.81 on Tuesday. The business’s fifty day moving average price is $1.92 and its 200-day moving average price is $1.65. Ascletis Pharma has a 1-year low of $0.62 and a 1-year high of $2.29.

About Ascletis Pharma

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).